Portfolio company
Scinus Group
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops automated, closed bioreactor systems for large-scale cell expansion, serving the cell therapy and regenerative medicine industries.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
PBS Biotech
This company manufactures scalable bioreactor systems and single-use vessels for customers developing and producing commercial cell therapies.
Biothrust
This company develops bionic bioreactors for bubble-free cell cultivation to enable scalable manufacturing for pharmaceutical firms, research institutions and therapy developers.
Cellular Origins
The company develops an automated robotic platform for cell therapy developers to manufacture and scale autologous and allogeneic therapies.
MFX
This company develops automated microfluidic bioreactor platforms and data generation infrastructure for researchers and manufacturers in the cell and gene therapy sector.
Stämm Biotech
This company develops automated microfluidic bioreactors for continuous production of biologics and cell therapies for pharmaceutical, biotechnology and cultivated meat organisations.
Ori Biotech
This company develops automated manufacturing platforms for cell and gene therapy developers to scale production of advanced medicines.
Orgonex
Orgonex develops automated bioreactor systems for organoid cultivation to assist researchers and pharmaceutical companies with large-scale cell expansion and drug development.
BioLamina
This company produces recombinant human laminin proteins used as cell culture substrates by researchers and regenerative medicine companies to develop stem cell therapies.
